European Fintech Company iCard Achieves Secure Customer Verification in Under 60 Seconds with Regula’s Solutions
7.5.2025 08:00:00 CEST | Business Wire | Press Release
iCard, a leading European e-money institution, has successfully upgraded its customer checks with Regula’s advanced biometric and document verification technologies. By integrating Regula Face SDK and Regula Document Reader SDK with its KYC (Know Your Customer) and risk assessment systems, iCard has moved to speedy, automated verification with improved fraud detection, and enhanced the overall experience for customers in 30+ countries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506829598/en/
iCard streamlines onboarding and boosts fraud prevention by integrating Regula’s document and biometric verification technologies (Graphic: Regula)
As a licensed fintech organization, iCard must comply with strict European KYC regulations while maintaining a robust risk assessment system alongside low-effort customer experience.
Prior to implementing Regula’s solutions, manual verification processes led to inefficiencies, longer wait times, increased fraud, and potential friction for users. Customers often had to re-upload photos or wait for manual reviews, causing delays—especially outside business hours. Additionally, iCard needed a more comprehensive document verification system that was capable of recognizing a broader range of ID types.
The Regula Solution: Fast and Fraud-Free Identity Verification
To modernize and automate its verification process, iCard selected Regula’s complete solution for document and biometric verification for its industry-leading accuracy, ease of integration, and ability to meet the company’s specific requirements.
- Regula Face SDK: Integrated into the iCard Digital Wallet app (Android and iOS), it provides fast and reliable biometric verification when a user logs in or performs a money transaction. The solution conducts instant liveness detection and face matching, preventing fraud attempts, including presentation attacks, deepfakes, or injected videos.
- Regula Document Reader SDK: Deployed in iCard’s back-office system, it automatically authenticates ID cards, passports, and residence permits, including previously unsupported paper-based IDs. Regula’s solution reads and authenticates data from multiple document zones, including MRZs (machine-readable zones), RFID chips, and barcodes, and cross-validates the information to detect any inconsistencies that may indicate fraud.
Tangible Business Benefits
The project was completed in just one month, and the impact has been immediate:
- Instant identity verification – Customers can now authenticate their identity in under a minute.
- Reduced operational costs – Automated verification processes have minimized manual reviews.
- Enhanced fraud prevention – Advanced biometric and document verification strengthen security measures.
- Increased conversion rates – Faster verification leads to a smoother onboarding experience and reduced drop-off rates.
“Implementing Regula Face SDK and Regula Document Reader SDK has optimized our internal processes while ensuring a seamless experience for iCard Digital Wallet customers. The integration was completed in a short period, resulting in fast and secure identity verification, improved operational efficiency, and reduced fraud risks—all while boosting customer satisfaction,” says Gabriela Anastasova, Chief Product Officer at iCard.
“In today’s fintech landscape, balancing security and user convenience is critical. Customers expect seamless access, while businesses must comply with strict regulations and defend against sophisticated fraud. We are proud to support iCard in finding that perfect balance. Our solutions ensure that every identity check is robust, automated, and frictionless, allowing fintech innovators like iCard to scale securely and efficiently,” comments Ihar Kliashchou, Chief Technology Officer at Regula.
To learn more about how iCard optimized identity verification with Regula’s solutions, read the full case study on Regula’s website.
About iCard
iCard is a licensed e-money institution and a leader in the European fintech sector. With over 18 years of experience, we deliver innovative payment services to both individual and business clients. Our mission is to make financial convenience accessible to everyone. That’s why we dedicate our time and resources to creating solutions that empower people and businesses to take full control of their funds, while ensuring a seamless customer experience through secure, innovative, and hassle-free financial and technological services.
Learn more at www.icard.com.
About Regula
Regula is a global developer of forensic devices and identity verification solutions. With our 30+ years of experience in forensic research and the most comprehensive library of document templates in the world, we create breakthrough technologies for document and biometric verification. Our hardware and software solutions allow over 1,000 organizations and 80 border control authorities globally to provide top-notch client service without compromising safety, security, or speed. Regula has been repeatedly named a Representative Vendor in the Gartner® Market Guide for Identity Verification.
Learn more at www.regulaforensics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250506829598/en/
Contacts
Kristina – ks@regulaforensics.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FuzeBox AI Named Founding Co-Author of SPUR Coalition Technical Committee on Verifying AI Content Use5.10.2026 15:00:00 CEST | Press Release
FuzeBox AI has been named by the SPUR Coalition, an international nonprofit of 37 news and media organizations, as one of four founding co-authors of its Evidence Profile Technical Committee, adopted Sept. 2, 2026, to draft an evidence profile for SPUR's Content Telemetry standard: a way for publishers to verify AI usage reports without depending on the reporting company's cooperation. Under SPUR's current standard, AI companies self-report their content use. A company that skips reporting leaves no record, and publishers can't check what they do receive. On July 10, 2026, FuzeBox proposed its Verified Provenance Telemetry Standard (VPTS): publishers seed content with detectable markers, then verify their appearance in AI outputs via an auditable ledger, with no change to SPUR's standard. Within 48 hours, three organizations filed related proposals: ProRata on usage magnitude, Encypher CEO Erik Svilich on the verification question FuzeBox raised, and LicenseFoundry on portable proof of
Mary Kay Introduces the K-Beauty Texture Edit5.10.2026 14:02:00 CEST | Press Release
Mary Kay Inc.,the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, aspecial-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005600130/en/ Mary Kay's Special Edition K-Beauty Texture Edit is a trend-forward collection which includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel. (Image Credit: Mary Kay Inc.) Inspired by Korea's globally influential skin care and self-care philosophy designed to bring playful textures, innovative ingredients, and elevated beauty experiences, the K-Beauty Texture Editwas designed to resonate with a global cultural beauty movement captivating the next gene
GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.5.10.2026 14:00:00 CEST | Press Release
GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subject to closing conditions, including regulatory approvals, at which time SOFIE Biosciences will become part of GE HealthCare’s PDx segment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005273717/en/ SOFIE Biosciences has 15 CMO sites across the U.S., manufacturing PET radiopharmaceutical products The acquisition of SOFIE Biosciences establishes a footprint for GE HealthCare in the time-critical ‘final mile’ of U.S. PET radiopharmaceutical supply, while also enabling PDx to participate in other high growth areas outside its own product portfolio. With a U.S. network of 15 CMO sites operating 21 cyclotrons, and a theranostics
Henkell Freixenet Strengthens Premium Dealcoholized Sparkling Wine Production with Solos' Patented Aroma Recovery System5.10.2026 13:24:00 CEST | Press Release
Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005959301/en/ Fürst von Metternich Riesling Alcohol-free on the bottling line, one of the first products in Henkell Freixenet’s portfolio developed in collaboration with Solos Technology. The project combines Henkell Freixenet's longstanding winemaking expertise with Solos' proprietary dealcoholization and patented aroma recovery technology. With 30 years of experience in producing alcohol-free sparkling wines, Henkell Fre
Croma-Pharma Expands Its Portfolio in Canada With saypha ® lips Lidocaine and Exprecell™5.10.2026 13:12:00 CEST | Press Release
Croma-Pharma continues to build its portfolio in Canada, adding saypha® lips Lidocaine, a hyaluronic acid filler for lip augmentation,1 and Exprecell™, a medical device for the preparation of autologous PRP | Fluid-PRF.2 Both are distributed by Renellence, Croma's partner in Canada since 2025. The two additions reflect Croma's broader approach: pairing established hyaluronic acid expertise with autologous, regenerative technologies. Together, they give practitioners options across both aesthetic and regenerative treatment categories, from a single trusted source. "With saypha® lips Lidocaine and Exprecell™, we're giving Canadian practitioners a wider set of tools for facial aesthetics and regenerative treatments, each held to the same standard of precision and safety," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. Renellence has distributed Croma's Saypha® hyaluronic acid filler range in Canada since October 2025, alongside medical education and training for Canadia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom